{
    "title": "US FDA approves Ardelyx's kidney disease-related drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12642587/US-FDA-approves-Ardelyxs-kidney-disease-related-drug.html",
    "date": "2023-10-17",
    "keywords": [
        "drug",
        "phosphate",
        "phosphorus",
        "treatment",
        "fda",
        "company",
        "condition",
        "blood",
        "launch",
        "ardelyx",
        "debt",
        "financing",
        "approval",
        "absorption",
        "food",
        "administration",
        "kidney",
        "disease",
        "tuesday",
        "xphozah",
        "level",
        "calcium",
        "body",
        "turn",
        "muscle",
        "skin",
        "use",
        "response",
        "intolerance",
        "binder",
        "standardofcare",
        "november",
        "statement",
        "agreement",
        "investment",
        "capital",
        "access",
        "tranche",
        "october",
        "health",
        "regulator",
        "tenapanor",
        "panel",
        "meeting",
        "appeal",
        "year",
        "therapy",
        "dialysis",
        "class",
        "inhibitor",
        "protein",
        "gut",
        "reporting",
        "kanjyik",
        "ghosh",
        "mariam",
        "khushi",
        "mandowara",
        "leo",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "syamnath",
        "subhranshu",
        "sahu"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}